Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
TriMas Corporation is a specialty industrial machinery business based in the US. TriMas Corporation shares (TRS) are listed on the NASDAQ and all prices are listed in US Dollars. TriMas Corporation employs 3,200 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$34.77|
|52-week range||$22.82 - $36.62|
|50-day moving average||$31.38|
|200-day moving average||$31.46|
|Wall St. target price||$47.00|
|Dividend yield||$0.16 (0.46%)|
|Earnings per share (TTM)||$-1.21|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-21)||1.52%|
|1 month (2021-09-28)||13.07%|
|3 months (2021-07-28)||4.73%|
|6 months (2021-04-28)||10.52%|
|1 year (2020-10-27)||45.42%|
|2 years (2019-10-25)||10.21%|
|3 years (2018-10-26)||26.71%|
|5 years (2016-10-27)||90.10%|
Valuing TriMas Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of TriMas Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
TriMas Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.63. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into TriMas Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
TriMas Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $156.2 million.
The EBITDA is a measure of a TriMas Corporation's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$813.4 million|
|Operating margin TTM||12.88%|
|Gross profit TTM||$204 million|
|Return on assets TTM||5.39%|
|Return on equity TTM||-8.31%|
|Market capitalisation||$1.5 billion|
TTM: trailing 12 months
There are currently 449,498 TriMas Corporation shares held short by investors – that's known as TriMas Corporation's "short interest". This figure is 0.3% up from 448,224 last month.
There are a few different ways that this level of interest in shorting TriMas Corporation shares can be evaluated.
TriMas Corporation's "short interest ratio" (SIR) is the quantity of TriMas Corporation shares currently shorted divided by the average quantity of TriMas Corporation shares traded daily (recently around 107023.33333333). TriMas Corporation's SIR currently stands at 4.2. In other words for every 100,000 TriMas Corporation shares traded daily on the market, roughly 4200 shares are currently held short.
However TriMas Corporation's short interest can also be evaluated against the total number of TriMas Corporation shares, or, against the total number of tradable TriMas Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case TriMas Corporation's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 TriMas Corporation shares in existence, roughly 10 shares are currently held short) or 0.0106% of the tradable shares (for every 100,000 tradable TriMas Corporation shares, roughly 11 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against TriMas Corporation.
Find out more about how you can short TriMas Corporation stock.
Dividend payout ratio: 2.19% of net profits
Recently TriMas Corporation has paid out, on average, around 2.19% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.46% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), TriMas Corporation shareholders could enjoy a 0.46% return on their shares, in the form of dividend payments. In TriMas Corporation's case, that would currently equate to about $0.16 per share.
While TriMas Corporation's payout ratio might seem low, this can signify that TriMas Corporation is investing more in its future growth.
TriMas Corporation's shares were split on a 1255:1000 basis on 30 June 2015. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1255 shares. This wouldn't directly have changed the overall worth of your TriMas Corporation shares – just the quantity. However, indirectly, the new 20.3% lower share price could have impacted the market appetite for TriMas Corporation shares which in turn could have impacted TriMas Corporation's share price.
Over the last 12 months, TriMas Corporation's shares have ranged in value from as little as $22.82 up to $36.62. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while TriMas Corporation's is 0.7344. This would suggest that TriMas Corporation's shares are less volatile than average (for this exchange).
TriMas Corporation manufactures and provides products for consumer products, aerospace, and industrial end markets worldwide. It operates in three segments: Packaging, Aerospace, and Specialty Products. The Packaging segment offers specialty polymeric and steel closure and dispensing systems, including dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, flexible spouts, and agricultural closures; polymeric jar products; integrated dispensers; bag-in-box products; aseptic closures; industrial closures and flex spouts; and single-bodied and assembled caps and closures under the Rieke, Taplast, Affaba & Ferrari, Stolz, and Rapak brands. The Aerospace segment provides fasteners, collars, blind bolts, rivets, ducting and connectors for air management systems, and machined parts and components to original equipment manufacturers, supply chain distributors, MRO/aftermarket providers, and tier one suppliers for commercial, maintenance, repair, and operations (MRO); and military and defense aerospace applications and platforms under the Monogram Aerospace Fasteners, Allfast Fastening Systems, Mac Fasteners, RSA Engineered Products, and Martinic Engineering brands. The Specialty Products segment offers steel cylinders for use in the transportation, storage, and dispensing of compressed gases under the Norris Cylinder brand; natural gas powered wellhead engines, compressors, and replacement parts for oil and natural gas production, and other industrial and commercial markets under the Arrow brand; and spare parts for various industrial engines. The company sells its products through a direct sales force, third-party agents, and distributors. TriMas Corporation was incorporated in 1986 and is headquartered in Bloomfield Hills, Michigan.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.